Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.39 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.39 (Delta)NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
AY.39 (Delta)NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
AY.39 (Delta)ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
AY.26 (Delta)ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-3603.41China
AY.26 (Delta)ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-3635.26China
AY.26 (Delta)ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
AY.26 (Delta)ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
AY.26 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.26 (Delta)NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
AY.26 (Delta)NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
AY.26 (Delta)ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
AY.103 (Delta)ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
AY.103 (Delta)ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
AY.103 (Delta)ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
AY.103 (Delta)ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
AY.103 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.103 (Delta)NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
AY.103 (Delta)NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
AY.103 (Delta)ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
AY.3 (Delta)ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-3603.41China
AY.3 (Delta)ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-3635.26China
AY.3 (Delta)ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
AY.3 (Delta)ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
AY.3 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.3 (Delta)NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
AY.3 (Delta)NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
AY.3 (Delta)ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
JN.1.18.7ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
JN.1.18.7ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
JN.1.18.7ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
JN.1.18.7ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
JN.1.18.7NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
JN.1.18.7NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
JN.1.18.7ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
MB.1ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-4251.49China
MB.1ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
MB.1ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-301.668South Korea
MB.1ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
MB.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
MB.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
MB.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
MB.1ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-3925.34Japan
LE.1ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
LE.1ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
LE.1ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
LE.1ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
LE.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LE.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
LE.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used